Fundraising Fox
/Companies
Sign in

ECM Therapeutics

Warrendale, US · Delaware corporation

Find your way into ECM Therapeutics

Sign up to see every warm intro you have to ECM Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ECM Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.

BiotechHealthtechMedical Devices

Founders & leadership

SBStephen Badylak
Stephen BadylakScientific Leader
PFPaul F. Fagan
Paul F. FaganExecutive
KCKatie Collins
Katie CollinsExecutive
CS
Christine SheehyExecutive
JD
Jenna DzikiNamed on SEC filing
GH
George HusseyNamed on SEC filing
LS
Lindsey SaldinNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$35.2M disclosed across 1 of 3 rounds · 2018–2025

▶$35.2MraisedOct 2025 · 190 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul F. FaganExecutive Officer, Director
  • Katie CollinsExecutive Officer, Director
  • Christine SheehyExecutive Officer
  • Jenna DzikiExecutive Officer
  • Stephen BadylakExecutive Officer, Director
  • George HusseyExecutive Officer
  • Lindsey SaldinExecutive Officer
Offering amount
$40M
Amount sold
$35.2M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
AbcamSupplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
DanaherDanaher is a global science and technology company specializing in biotech, diagnostics, and life sciences with businesses that innovate in drug development, molecular diagnostics, genomic medicine, and bioprocessing to help advance human health. Operating through multiple strategic platforms and with nearly 63,000 employees, Danaher develops technologies and solutions for researchers, biopharmaceutical producers, and healthcare systems globally.
VaiaVaia is a learning app that gives students AI-generated explanations, flashcards, notes, mock exams, and study sets, along with study modes like spaced repetition. It serves students preparing for exams, offering tools to create and organize learning materials across phone, tablet, and laptop.

Companies working in the same space as ECM Therapeutics.

Frequently asked questions

What does ECM Therapeutics do?
ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.
Who founded ECM Therapeutics?
ECM Therapeutics was founded by Stephen Badylak.
How much funding has ECM Therapeutics raised?
ECM Therapeutics has disclosed $35.2M raised across 1 of its 3 known rounds.
Where is ECM Therapeutics headquartered?
ECM Therapeutics is headquartered in Warrendale, US.